General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-14 | 2024-03 | -2.2 | -2.4 | -0.2 | -9.09% |
2024-03-28 | 2023-12 | -2 | -2.01 | -0.01 | -0.50% |
2024-03-28 | 2023-12 | -2 | N/A | N/A | N/A |
2023-11-14 | 2023-09 | -2.75 | -2.25 | 0.5 | 18.18% |
2023-11-14 | 2023-09 | -2.75 | N/A | N/A | N/A |
2023-08-15 | 2023-06 | -5 | -3.5 | 1.5 | 30.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-05-24 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-03-21 | JonesTrading | Upgrade | Buy | |
2023-03-16 | HC Wainwright & Co. | Upgrade | Buy | |
2022-03-28 | B. Riley Securities | Upgrade | Buy | |
2021-03-04 | HC Wainwright & Co. | Upgrade | Buy | |
2021-02-07 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-08-15 | CARLSON CAPITAL, L.P. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-08-14 | COLEMAN KIRK ALLEN | Chief Financial Officer | 35.67K | Purchase |
2022-11-21 | FLETCHER AARON G.L. | Director | 795.07K | Purchase |
2022-05-15 | MATTES GLENN R. | Chief Executive Officer | 43.00K | Purchase |
2023-08-14 | MIKHAK ZAMANEH | Officer | 135.00K | Purchase |
2023-08-14 | MILLS ROBERT S | Director | 55.98K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | AIGH Capital Management LLC | 1.56M | 731.10K | 2.63% |
2023-06-29 | Carlson Capital. L.P. | 1.28M | 601.60K | 2.16% |
2023-06-29 | Drw Securities, Llc | 1000.00K | 470.00K | 1.69% |
2023-06-29 | Vanguard Group Inc | 853.66K | 401.22K | 1.44% |
2023-06-29 | Worth Venture Partners, Llc | 389.11K | 182.88K | 0.66% |
2023-06-29 | Blackrock Inc. | 213.90K | 100.53K | 0.36% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 562.69K | 264.46K | 0.95% |
2023-06-29 | Vanguard Extended Market Index Fund | 268.77K | 126.32K | 0.45% |
2023-05-30 | Fidelity Extended Market Index Fund | 107.82K | 49.60K | 0.18% |
2023-05-30 | Fidelity Total Market Index Fund | 28.26K | 13.00K | 0.05% |
2023-05-30 | Fidelity Series Total Market Index Fund | 24.33K | 11.19K | 0.04% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 17.91K | 6.97K | 0.03% |
Split | Date |
---|---|
1 : 25 | 2023-12-19 |
DRUG PIPELINE
ANALYST RATINGS
INSIDER TRADES
NEWS
$0.71
+0.04 (+5.97%)
PREVIOUS CLOSE
0.67
OPEN
0.65
52 WEEK LOW
0.53
52 WEEK HIGH
6.73
MARKET CAP
$26M
SHARES
36M
FLOAT
36M
ENTERPRISE VALUE
$11M
VOLUME
243K
AV. DAILY VOLUME
146K
COMPANY CASH DATABASE
LIVE CASH EST
$10.05M
CASH BURN
-$1.45M
NO. MTHS CASH
6.95
INSIDERS %
0.7
TOTAL DEBT TO EQUITY
0.01
BIOTECH EARNINGS CALENDAR
EARNINGS DATE
05/11/2023
EPS EST.
-0.230
EPS PRIOR.
-0.330
EPS
-0.190
REV GUIDANCE
$67.44K
Upcoming TFFP Catalysts
DRUG
STAGE
CATALYST DATE
Voriconazole Inhalation Powder - (VORI)
Invasive Pulmonary Aspergillosis (IPA)
Phase 2
2023
Phase 2 trial data reported that previously intolerant to oral voriconazole therapy successfully treated with TFF VORI, noted September 8, 2022. Phase 2 trial data showed that second patient treated to clinically benefit from administration in compassionate use program, noted November 1, 2022. Phase 2 data due in 2023.
Tacrolimus Inhalation Powder
Lung transplant (post)
Phase 2
2Q 2023
Phase 2 trial initiated, noted May 11, 2022. Phase 2 data due in 2Q 2023.
HARE
Kirk Allen Coleman Chief Financial Officer 09/03/2023 Buy Stock 12K 326.53% $0.79 $9,457.20 15.68K
Harlan F Weisman Director 09/03/2023 Buy Stock 150K 232.14% $0.88 $131,835.00 214.62K
Zamaneh Mikhak Chief Medical Officer 09/03/2023 Buy Stock 15K 0% $0.82 $12,300.00 15K
Stephen Rocamboli Director 09/03/2023 Buy Stock 13K 433.33% $0.80 $10,432.50 16K
Aaron G.L. Fletcher Director 21/11/2022 Buy Option 1.29 21.74K 0% $0.00 $0.00 21.74K
Aaron G.L. Fletcher Director 21/11/2022 Buy Stock 43.47K 43.47% $1.15 $49,990.50 143.47K
Well, I think I’m done playing games with $TFFP.
Not sure what to think of $TFFP anymore. ️
I just averaged down...gonna keep averaging down $TFFP
Bought back in bud way too high, such a terrible trader lol $TFFP I have faith she’s going over 20 by EOY
I playing this so terrible the last 2 days...$TFFP been holding since 13 sold yesterday for EV plays at 16.98 and of course she pops
Errrrt this thing is bipolar $TFFP
I like how there aren’t a lot of people chatting on here about $TFFP I don’t like pumpers.
Options looking terrible for the bulls on $TFFP what is gonna happen with this one?
I really do not appreciate this market right now....I told. Shelf to sell and sideline everything before October and completely did not execute my game plan now I’m down 30%. I would love to have cash on hand to buy this overall market dip $TFFP
Wow I thought I lost cell service earlier when I looked at this board...apparently no one likes talking about $TFFP
Guys the whole market tanked today on negative stimulus...were in an election season everything is going to be weird...average down $TFFP
I guess I am gonna reload soon $TFFP